Updated: January 21, 2026
How to Save Money on Entrectinib in 2026: Coupons, Discounts, and Patient Assistance
Author
Peter Daggett

Summarize with AI
- How Much Does Entrectinib Cost Without Insurance?
- Option 1: Genentech Oncology Co-pay Assistance Program
- Option 2: Genentech Patient Foundation (Free Drug for Qualifying Patients)
- Option 3: Independent Co-pay Assistance Foundations
- Option 4: Medicare Extra Help (Low Income Subsidy)
- Are There Coupons or GoodRx Discounts for Rozlytrek?
- Tips to Maximize Your Savings
- The Bottom Line
Rozlytrek (entrectinib) can cost ~$8,000/month without assistance. Here's every legitimate way to reduce your out-of-pocket cost in 2026, including Genentech programs.
Entrectinib (brand name Rozlytrek) is one of the most expensive oral cancer drugs on the market. Without insurance or financial assistance, a 28-day supply costs approximately $8,000. There is no FDA-approved generic. But there are several legitimate programs that can bring your cost down significantly — or even to zero. Here's everything you need to know in 2026.
How Much Does Entrectinib Cost Without Insurance?
The full cash price for Rozlytrek is approximately $8,000 per 28-day supply for adult patients taking the standard 600 mg once-daily dose. Since adults typically take three 200 mg capsules (or six 100 mg capsules) per day, a one-month supply requires 90 or more capsules. At retail rates from specialty pharmacies, this works out to roughly $8,000/month or approximately $96,000/year. There is currently no generic alternative available.
Option 1: Genentech Oncology Co-pay Assistance Program
This is the most powerful cost-reduction tool available for commercially insured patients. Eligible patients may pay $0 out of pocket for Rozlytrek, with Genentech covering up to $25,000 in costs per product per calendar year. To qualify, you must:
Have commercial (non-government) insurance that covers Rozlytrek
Be a U.S. resident
Not be enrolled in a federal or state healthcare program (Medicare, Medicaid, Tricare, VA)
Contact Genentech Access Solutions at 877-436-3683 to enroll. Your oncologist's office can also initiate enrollment on your behalf.
Option 2: Genentech Patient Foundation (Free Drug for Qualifying Patients)
The Genentech Patient Foundation provides Rozlytrek at no charge to patients who are uninsured, underinsured, or who cannot otherwise afford their medication. Qualification is based on income and insurance status. Your oncologist can submit an application on your behalf by contacting Genentech Access Solutions (877-436-3683).
Option 3: Independent Co-pay Assistance Foundations
If you are on Medicare or Medicaid and don't qualify for Genentech's commercial co-pay program, independent nonprofit foundations may be able to help. Genentech Access Solutions can refer you to the right organizations. Options include:
CancerCare Co-Payment Assistance Foundation — provides grants for cancer drug copays
Patient Access Network Foundation (PANF) — assists patients with coverage gaps and high out-of-pocket costs
HealthWell Foundation — provides assistance for patients with serious chronic illnesses
The Leukemia and Lymphoma Society — available for hematologic cancer patients
Option 4: Medicare Extra Help (Low Income Subsidy)
If you're on Medicare Part D with a low income, you may qualify for Medicare Extra Help (also called the Low Income Subsidy or LIS). This federal program significantly reduces your Part D premiums and cost-sharing for specialty drugs like Rozlytrek. Ask your oncologist's social worker or contact the Social Security Administration at 1-800-772-1213 to apply.
Are There Coupons or GoodRx Discounts for Rozlytrek?
Because Rozlytrek is a specialty medication with no generic version, traditional drug discount programs like GoodRx do not typically offer meaningful discounts. Rozlytrek is available only through specialty pharmacies, which don't accept standard discount cards. The most effective cost-reduction strategy remains Genentech's manufacturer co-pay program or the independent foundations listed above.
Tips to Maximize Your Savings
Enroll in Genentech's copay program before your first fill, not after you've paid out of pocket
Ask your oncologist if you qualify for a clinical trial that provides the drug at no cost
Track the calendar-year cap on co-pay assistance ($25,000/year) and plan for what happens when it resets in January
Ask your social worker about state pharmaceutical assistance programs (SPAPs) if you're on Medicare and your income is above Extra Help limits but you still can't afford the copay
The Bottom Line
The $8,000/month cost of Rozlytrek is daunting, but most commercially insured patients and many uninsured patients can access significant financial assistance through Genentech and independent foundations. Start the conversation with your oncologist's office and Genentech Access Solutions (877-436-3683) before your first fill. And if you're having trouble finding a specialty pharmacy that can fill your prescription, medfinder can help by contacting pharmacies near you. See also our guide to finding entrectinib in stock near you.
Frequently Asked Questions
Without insurance, Rozlytrek (entrectinib) costs approximately $8,000 per 28-day supply for adult patients at the standard 600 mg once-daily dose. There is no FDA-approved generic, so there is no lower-cost generic alternative available.
Yes. Eligible commercially insured patients may pay $0 out of pocket for Rozlytrek through Genentech's co-pay assistance program, with savings of up to $25,000 per product per calendar year. Government-insured patients (Medicare, Medicaid) do not qualify for this specific program but may be eligible for independent foundation assistance.
Yes. The Genentech Patient Foundation provides Rozlytrek at no charge to qualifying uninsured and underinsured patients based on income and insurance status. Contact Genentech Access Solutions at 877-436-3683 to apply or have your oncologist's office apply on your behalf.
No. Because Rozlytrek is a specialty medication dispensed only through specialty pharmacies, standard drug discount programs like GoodRx typically do not offer meaningful discounts. The most effective approach is Genentech's manufacturer co-pay program or independent foundation assistance.
Medicare patients do not qualify for Genentech's commercial co-pay program, but may be eligible for Medicare Extra Help (Low Income Subsidy) through the Social Security Administration, or for assistance from independent foundations like CancerCare, PANF, or HealthWell Foundation. Genentech Access Solutions (877-436-3683) can help identify the right programs.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Entrectinib also looked for:
More about Entrectinib
35,948 have already found their meds with Medfinder.
Start your search today.





